Shikibo Ltd.
Shikibo Ltd. (3109.T) Financial Performance & Income Statement Overview
Explore the financials of Shikibo Ltd. (3109.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Shikibo Ltd. (3109.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Shikibo Ltd. 3109.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $10.81B | $9.37B | $9.62B | $9.29B |
| Cost of Revenue | $8.85B | $7.57B | $7.86B | $7.57B |
| Gross Profit | $1.96B | $1.80B | $1.76B | $1.72B |
| Gross Profit Ratio | $0.18 | $0.19 | $0.18 | $0.18 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.51B | $1.45B | $1.47B | $1.46B |
| Operating Expenses | $1.51B | $1.45B | $1.47B | $1.47B |
| Total Costs & Expenses | $10.37B | $9.01B | $9.33B | $9.04B |
| Interest Income | $7.00M | $5.00M | $8.00M | $4.00M |
| Interest Expense | $174.00M | $66.00M | $63.00M | $56.00M |
| Depreciation & Amortization | $626.00M | $477.50M | $479.00M | $469.75M |
| EBITDA | $968.00M | $875.00M | $721.00M | $722.75M |
| EBITDA Ratio | $0.09 | $0.09 | $0.07 | $0.08 |
| Operating Income | $442.00M | $356.00M | $296.00M | $252.00M |
| Operating Income Ratio | $0.04 | $0.04 | $0.03 | $0.03 |
| Other Income/Expenses (Net) | $30.00M | -$23.00M | -$117.00M | $1.00M |
| Income Before Tax | $472.00M | $333.00M | $179.00M | $253.00M |
| Income Before Tax Ratio | $0.04 | $0.04 | $0.02 | $0.03 |
| Income Tax Expense | $63.00M | $136.00M | $64.00M | $60.00M |
| Net Income | $408.00M | $198.00M | $116.00M | $192.00M |
| Net Income Ratio | $0.04 | $0.02 | $0.01 | $0.02 |
| EPS | $32.21 | $15.64 | $9.20 | $15.56 |
| Diluted EPS | $32.21 | $15.64 | $9.20 | $15.56 |
| Weighted Avg Shares Outstanding | $12.67M | $12.66M | $12.61M | $12.34M |
| Weighted Avg Shares Outstanding (Diluted) | $12.67M | $12.66M | $12.61M | $12.34M |
Over the past four quarters, Shikibo Ltd. demonstrated steady revenue growth, increasing from $9.29B in Q1 2024 to $10.81B in Q4 2024. Operating income reached $442.00M in Q4 2024, maintaining a consistent 4% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $968.00M, reflecting operational efficiency. Net income rose to $408.00M, with EPS at $32.21. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan